Company Profile

Genospace LLC
Profile last edited on: 3/26/18      CAGE: 6Y7K4      UEI:

Business Identifier: Precision medicine software: comprehensive suite of tools to enable broad use of genomic data in research and clinical care
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

700 Massachusetts Avenue Third Floor
Cambridge, MA 02139
   (617) 444-9314
Location: Single
Congr. District: 07
County: Middlesex

Public Profile

In January 2017, Sarah Cannon, the Cancer Institute of Hospital Corporation of America (HCA) announced that Genospace, LLC, a cloud-based software company focused on advancing personalized medicine, would merge with its organization and become a wholly-owned subsidiary. By joining forces, the effort will be to have Sarah Cannon and Genospace together harness and use molecular profiling data to more effectively match cancer patients to cutting-edge therapies in clinical trials. Describing themselves as Digital Architects of Genomic Medicine™. GenoSpace has been a precision medicine software company developing a comprehensive suite of offerings for securely storing genomic and health data, and providing it in formats specific to its diverse user communities. GenoSpace for Clinical™ and GenoSpace for Labs™ facilitate clinically actionable interpretation and report generation for precision medicine. GenoSpace for Research™ provides dynamic analysis, visualization and collaboration tools on an advanced population analytics platform. GenoSpace for Patient Communities™ enables patient-centric exploration and advancement of personalized m

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2014 1 NIH $136,701
Project Title: Enabling Access and Cohort Construction for Biorepositories

Key People / Management

  Mick A Correll -- CEO

  Daniel Meyer -- Chief Operating Officer

  Niall O'connor -- Chief Technology Officer

  John Quackenbush -- Chairman Founder